Integrates several technologies and sample types into a single Instrument, allowing for a continued development of a broad test menu across conditions diagnosed and managed in community-based healthcare settings.
Improved economic value
Replaces multiple point of care systems with a single Platform, increasing efficiency through reduced training, equipment, maintenance and test supplies.
LumiraDx’s next generation, point of care diagnostic Platform is designed to be affordable and accessible for healthcare providers globally and intends to strengthen community-based healthcare.
Currently offering COVID‑19, CRP, D‑Dimer, Flu, HbA1c, INR, NT‑proBNP and RSV test capabilities, with a pipeline of over 30 tests across a range of assay technologies including enzyme, immunoassay, molecular and electrolyte assays. All carried out on one, easy to use device.
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets. *As stated at time of publication - 17th April 2023
Our latest Cloud-based technology empowers healthcare professionals with effortless data reporting, analytics, and decision support.